1 |
Smith TCA, Arndt PF, Eyre-Walker A. Large scale variation in the rate of germ-line de novo mutation, base composition, divergence and diversity in humans. PLoS Genet 2018;14:e1007254.
DOI
|
2 |
Acuna-Hidalgo R, Veltman JA, Hoischen A. New insights into the generation and role of de novo mutations in health and disease. Genome Biol 2016;17:241.
DOI
|
3 |
Willsey AJ, Sanders SJ, Li M, Dong S, Tebbenkamp AT, Muhle RA, et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 2013;155:997-1007.
DOI
|
4 |
Sugathan A, Biagioli M, Golzio C, Erdin S, Blumenthal I, Manavalan P, et al. CHD8 regulates neurodevelopmental pathways associated with autism spectrum disorder in neural progenitors. Proc Natl Acad Sci U S A 2014;111:E4468-E4477.
DOI
|
5 |
Cotney J, Muhle RA, Sanders SJ, Liu L, Willsey AJ, Niu W, et al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat Commun 2015;6:6404.
DOI
|
6 |
An JY, Lin K, Zhu L, Werling DM, Dong S, Brand H, et al. Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder. Science 2018;362:eaat6576.
DOI
|
7 |
McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GR, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol 2016;17:122.
DOI
|
8 |
Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes. Cold Spring Harbor: bioRXiv, Cold Spring Harbor Laboratory, 2019. Accessed 2018 Sep 10. Available from: https://doi.org/10.1101/531210.
|
9 |
Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res 2019;47:D941-D947.
DOI
|
10 |
Diaz-Gay M, Vila-Casadesus M, Franch-Exposito S, Hernandez-Illan E, Lozano JJ, Castellvi-Bel S. Mutational Signatures in Cancer (MuSiCa): a web application to implement mutational signatures analysis in cancer samples. BMC Bioinformatics 2018;19:224.
DOI
|
11 |
Frankish A, Diekhans M, Ferreira AM, Johnson R, Jungreis I, Loveland J, et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res 2019;47:D766-D773.
DOI
|
12 |
Gel B, Serra E. karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data. Bioinformatics 2017;33:3088-3090.
DOI
|
13 |
Heger A, Webber C, Goodson M, Ponting CP, Lunter G. GAT: a simulation framework for testing the association of genomic intervals. Bioinformatics 2013;29:2046-2048.
DOI
|
14 |
Karolchik D, Hinrichs AS, Furey TS, Roskin KM, Sugnet CW, Haussler D, et al. The UCSC Table Browser data retrieval tool. Nucleic Acids Res 2004;32:D493-D496.
DOI
|
15 |
Landrum MJ, Lee JM, Benson M, Brown GR, Chao C, Chitipiralla S, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 2018;46:D1062-D1067.
DOI
|
16 |
Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 2019;47:D886-D894.
DOI
|
17 |
Francis WR, Worheide G. Similar ratios of introns to intergenic sequence across animal genomes. Genome Biol Evol 2017;9:1582-1598.
DOI
|
18 |
DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 2011;43:491-498.
DOI
|
19 |
Li M, Chen SS. The tendency to recreate ancestral CG dinucleotides in the human genome. BMC Evol Biol 2011;11:3.
DOI
|
20 |
Halder B, Malakar AK, Chakraborty S. Nucleotide composition determines the role of translational efficiency in human genes. Bioinformation 2017;13:46-53.
DOI
|
21 |
Domanska D, Vodak D, Lund-Andersen C, Salvatore S, Hovig E, Sandve GK. The rainfall plot: its motivation, characteristics and pitfalls. BMC Bioinformatics 2017;18:264.
DOI
|
22 |
Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012;149:979-993.
DOI
|
23 |
Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature 2013;500:415-421.
DOI
|
24 |
Rahbari R, Wuster A, Lindsay SJ, Hardwick RJ, Alexandrov LB, Turki SA, et al. Timing, rates and spectra of human germline mutation. Nat Genet 2016;48:126-133.
DOI
|
25 |
Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, et al. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 2017;19:1105-1117.
DOI
|
26 |
Milone M, Shen XM, Selcen D, Ohno K, Brengman J, Iannaccone ST, et al. Myasthenic syndrome due to defects in rapsyn: clinical and molecular findings in 39 patients. Neurology 2009;73:228-235.
DOI
|
27 |
Maselli R, Dris H, Schnier J, Cockrell J, Wollmann R. Congenital myasthenic syndrome caused by two non-N88K rapsyn mutations. Clin Genet 2007;72:63-65.
DOI
|
28 |
Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010;42:790-793.
DOI
|
29 |
Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005;15:1034-1050.
DOI
|
30 |
Lindhurst MJ, Sapp JC, Teer JK, Johnston JJ, Finn EM, Peters K, et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011;365:611-619.
DOI
|
31 |
Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, Rosenbaum J, et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012;74:285-299.
DOI
|
32 |
Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013;498:220-223.
DOI
|
33 |
Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet 2012;13:565-575.
DOI
|